FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 Before and After: 1 Amazing Transformation The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling